About Neovasc

Neovasc Inc. is a specialty medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular marketplace.

Our products include the Tiara™ technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer™ for the treatment of refractory angina.

A Canadian biotech company, headquartered in Vancouver, B.C. Canada, we are a publicly traded company, listed on NASDAQ: (NVCN) and the Toronto Stock Exchange TSX: (NVCN) 

We invite you to register to receive Neovasc news updates  by email.